polyclonal antibody against mica micb (R&D Systems)
Structured Review

Polyclonal Antibody Against Mica Micb, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal antibody against mica micb/product/R&D Systems
Average 92 stars, based on 4 article reviews
Images
1) Product Images from "Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells"
Article Title: Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells
Journal: Journal of Experimental & Clinical Cancer Research : CR
doi: 10.1186/1756-9966-30-37
Figure Legend Snippet: Cervical cancer cell lines express MICA, MICB and NKG2D . CALO and INBL cells ( 1 × 10 7 ) were lysed proteins immunoprecipitated and equal amounts of protein from total lysates were resolved by SDS-PAGE and transferred to nitrocellulose membranes. The blots were developed with either polyclonal anti-MIC antibodies (A) or monoclonal anti-NKG2D antibodies (B) and an appropriate secondary antibody conjugated to HRP for chemiluminescence detection. Flow cytometric analysis of NKG2D expression in cervical carcinoma cell lines after 72 h induction with 10 ng MICB (C). We used only MICB to induce the expression of NKG2D because we previously obtained that MICB was a better inducer of myelomonocytic cell proliferation than MICA. Graphs show NKG2D levels (solid line) and isotype controls (dotted line).
Techniques Used: Immunoprecipitation, SDS Page, Expressing